SCHEMBL15399462

SCHEMBL15399462

NS(=O)(=O)Oc1ccc2c(=O)c(-c3ccc(OS(N)(=O)=O)c([N+](=O)[O-])c3)coc2c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STS P08842 3/20 0.63
MAPT P10636 7/20 0.50
NPC1 O15118 6/20 0.50
RAB9A P51151 6/20 0.50
ALOX12 P18054 1/20 0.49
KIF11 P52732 5/20 0.48
SMN1; SMN2 Q16637 3/20 0.44
LMNA P02545 1/20 0.44
KDM4E B2RXH2 4/20 0.43
POLB P06746 1/20 0.43
HMGB1 P09429 1/20 0.43
XDH P47989 1/20 0.43
HTT P42858 1/20 0.43
TP53 P04637 3/20 0.42
MEN1 O00255 2/20 0.42
ALDH1A1 P00352 2/20 0.42
CYP3A4 P08684 2/20 0.42
HPGD P15428 2/20 0.42
KMT2A Q03164 2/20 0.42
MAOA P21397 4/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17988699 0.90 STS (0.49) STSMAPTNPC1RAB9AALOX12
SCHEMBL17991978 0.88 MAPT (0.50) STSMAPTNPC1RAB9AALOX12
SCHEMBL15398873 0.84 STS (0.66) STSMAPTNPC1RAB9AALOX12
SCHEMBL15399710 0.84 STS (0.69) STSMAPTNPC1RAB9ASMN1; SMN2
SCHEMBL17991989 0.83 MAPT (0.61) MAPTNPC1RAB9AALOX12KIF11
SCHEMBL15398655 0.83 MAPT (0.58) STSMAPTNPC1RAB9AALOX12
SCHEMBL17991990 0.83 MAPT (0.58) STSMAPTNPC1RAB9AALOX12
SCHEMBL15398844 0.79 STS (0.65) STSMAPTNPC1RAB9ASMN1; SMN2
SCHEMBL17988698 0.78 STS (0.58) STSMAPTNPC1RAB9AALOX12
SCHEMBL17988696 0.77 ALOX12 (0.47) STSMAPTNPC1RAB9AALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9409859-B2 Substituted diphenyl derivatives CREATIVE THERAPEUTICS GMBH (DE) 2016-08-09 US disclosed
US-20140005149-A1 Substituted diphenyl derivatives CREATIVE THERAPEUTICS GMBH (DE) 2014-01-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140005149-A1 Substituted diphenyl derivatives DPYD, VHL, TP53 STS 3633/4885MAPT 3367/4885NPC1 1753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.